Using light to track zinc signals in Alzheimer's and Parkinson's brains
Analytical Tools for Light-Initiated Zn2+ Signaling in Neurodegenerative Disease
Researchers are developing light-based tools to spot how zinc and oxidative stress change brain cell communication in people with Alzheimer's and Parkinson's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project ID | NIH-11241124 on NIH RePORTER |
What this research studies
As someone affected by Alzheimer's or Parkinson's, this work is developing light-activated sensors to see when and where ionic zinc (Zn2+) is released in the brain and how reactive oxygen species change zinc binding on key proteins. The team will combine optical methods, chemical sensors, and disease models to map zinc-driven signaling that controls neurotransmitter release and uptake. By visualizing these events, scientists hope to link zinc and oxidative damage to the loss of neuronal function and memory problems. The new tools aim to fill current gaps that have slowed progress toward therapies targeting metal and oxidative-stress pathways.
Who could benefit from this research
Good fit: People diagnosed with Alzheimer's disease or Parkinson's disease who are willing to provide samples or take part in future translational studies would be the most relevant participants.
Not a fit: People without neurodegenerative disease or those seeking an immediate treatment effect are unlikely to receive direct benefit from this basic science work.
Why it matters
Potential benefit: If successful, these tools could reveal how zinc and oxidative stress harm neurons and guide new diagnostics or treatments for Alzheimer's and Parkinson's.
How similar studies have performed: Prior studies have linked zinc and oxidative stress to neurodegeneration, but light-initiated analytical tools for tracking Zn2+ signaling are largely novel and underdeveloped.
Where this research is happening
Lawrence, United States
- University of Kansas Lawrence — Lawrence, United States (Active)
Researchers
- Principal investigator: Johnson, Michael a. — University of Kansas Lawrence
- Study coordinator: Johnson, Michael a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.